Follow this link to join my WhatsApp group: https://chat.whatsapp.com/KO9jPR5BXR01gl9vzHkO4l
aneelnbamb🇮🇳❤️ (@aneelnbamb9) Tweeted: A fundamental comparison btw #brightcomgroup vs #Affle & #Vertoz as on 10-06-2021 closing basis
#brightcomgroup is far better fundamental in comparison with other 2
will start a dream run from here for next few years
Bright days ahead
Closing above 14.5
#animalspiritOfMarket https://t.co/HEcYtzYKpW https://twitter.com/aneelnbamb9/status/1403153419666214912?s=20
#brightcomgroup is far better fundamental in comparison with other 2
will start a dream run from here for next few years
Bright days ahead
Closing above 14.5
#animalspiritOfMarket https://t.co/HEcYtzYKpW https://twitter.com/aneelnbamb9/status/1403153419666214912?s=20
Twitter
aneelnbamb🇮🇳❤️
A fundamental comparison btw #brightcomgroup vs #Affle & #Vertoz as on 10-06-2021 closing basis #brightcomgroup is far better fundamental in comparison with other 2 will start a dream run from here for next few years Bright days ahead Closing above 14.5 …
World Markets
Dow + 19
Nasdaq + 109
Dax - 10
Nikkei + 54
Hangseng + 197
Sgxnifty + 34 (15787)
Brent Crude 72.32
Dow Fut + 13
Dollar Index 90.03
Dow + 19
Nasdaq + 109
Dax - 10
Nikkei + 54
Hangseng + 197
Sgxnifty + 34 (15787)
Brent Crude 72.32
Dow Fut + 13
Dollar Index 90.03
Ion Exchange (India) Ltd Q4FY21 Con-Call Update
(Nirmal Bang Retail Research)
Outlook: Positive in long term
*Company guided for 20% revenue growth and stable yearly margin*
• The company had a revenue of Rs. 445.2 Cr in Q4FY21 which grew by 27.5% YoY
• The geographical breakup for FY21: Domestic sales are at 58% and exports are at 42%
• The engineering segment (63% of total revenue) witnessed steady flow of orders during the quarter. Order book for engineering projects up to 31st March’21 is at Rs. 662 Cr
• Recently The company has been awarded a contract under the Jal Jivan Mission for the rural drinking water supply to 1000 villages in two districts of Uttar Pradesh namely Varanasi and Aligarh
• The value of this project is approximately Rs 1000 Cr and details regarding it will be out post approval of the detailed report and the project should be constructed and commissioned within 21 months of signing of the contract
• The execution of the Sri Lanka project improved during the quarter but frequent COVID related restrictions in the country continue to pose execution challenge.
• Order execution of other on-going Engineering orders further picked up pace resulting in improved sales and margins. The Bid pipeline project as of 31st March’ 21 is at Rs. 6000 Cr
• In the chemicals segment (30%), sales and dispatches showed continued improvement and margins improved due to higher turnover coupled with operational efficiencies
• In the consumer products segment (7%), volumes increased but was constrained due to certain segments continuing to remain affected due to restrained economic resumption in key consumer sectors and after effects of the COVID lockdown measures and continued social restrictions.
• In the chemical segment, the company had planned a capex of Rs. 100 Cr which will increase in the coming quarter for a new plan with higher capacity and details should be out in the coming quarter
• The company expects margins to be sustainable
• The chemical business has an asset utilization of 70% for the year
Share is trading at P/E of 17.3x FY22E EPS
(Nirmal Bang Retail Research)
Outlook: Positive in long term
*Company guided for 20% revenue growth and stable yearly margin*
• The company had a revenue of Rs. 445.2 Cr in Q4FY21 which grew by 27.5% YoY
• The geographical breakup for FY21: Domestic sales are at 58% and exports are at 42%
• The engineering segment (63% of total revenue) witnessed steady flow of orders during the quarter. Order book for engineering projects up to 31st March’21 is at Rs. 662 Cr
• Recently The company has been awarded a contract under the Jal Jivan Mission for the rural drinking water supply to 1000 villages in two districts of Uttar Pradesh namely Varanasi and Aligarh
• The value of this project is approximately Rs 1000 Cr and details regarding it will be out post approval of the detailed report and the project should be constructed and commissioned within 21 months of signing of the contract
• The execution of the Sri Lanka project improved during the quarter but frequent COVID related restrictions in the country continue to pose execution challenge.
• Order execution of other on-going Engineering orders further picked up pace resulting in improved sales and margins. The Bid pipeline project as of 31st March’ 21 is at Rs. 6000 Cr
• In the chemicals segment (30%), sales and dispatches showed continued improvement and margins improved due to higher turnover coupled with operational efficiencies
• In the consumer products segment (7%), volumes increased but was constrained due to certain segments continuing to remain affected due to restrained economic resumption in key consumer sectors and after effects of the COVID lockdown measures and continued social restrictions.
• In the chemical segment, the company had planned a capex of Rs. 100 Cr which will increase in the coming quarter for a new plan with higher capacity and details should be out in the coming quarter
• The company expects margins to be sustainable
• The chemical business has an asset utilization of 70% for the year
Share is trading at P/E of 17.3x FY22E EPS
*Tide Water Oil Company (India) Ltd.* | *CMP* Rs. 10912 | *M Cap* Rs. 3803 Cr | *52 W H/L* 10912/3315
(Nirmal Bang Retail Research)
*Result ok*
*Board approved*
*Sub-division of face value of shares from Rs.5/- to Rs.2/- each fully paid*
*Issue of Bonus shares at a ratio 1:1 after sub-division of shares*
*Recommended Dividend of Rs.200/share*
Revenue from Operations came at Rs. 364.7 Cr (0.1% QoQ, 19.6% YoY) vs QoQ Rs. 364.3 Cr, YoY Rs. 305 Cr
EBIDTA came at Rs. 43 Cr (-23.6% QoQ, 55.3% YoY) vs QoQ Rs. 56.2 Cr, YoY Rs. 27.7 Cr
EBITDA Margin came at 11.8% vs QoQ 15.4%, YoY 9.1%
Adj. PAT came at Rs. 36.7 Cr vs QoQ Rs. 47.7 Cr, YoY Rs. 23.2 Cr
Quarter EPS is Rs. 105.2
Share is trading at P/E of 26.9x TTM EPS
(Nirmal Bang Retail Research)
*Result ok*
*Board approved*
*Sub-division of face value of shares from Rs.5/- to Rs.2/- each fully paid*
*Issue of Bonus shares at a ratio 1:1 after sub-division of shares*
*Recommended Dividend of Rs.200/share*
Revenue from Operations came at Rs. 364.7 Cr (0.1% QoQ, 19.6% YoY) vs QoQ Rs. 364.3 Cr, YoY Rs. 305 Cr
EBIDTA came at Rs. 43 Cr (-23.6% QoQ, 55.3% YoY) vs QoQ Rs. 56.2 Cr, YoY Rs. 27.7 Cr
EBITDA Margin came at 11.8% vs QoQ 15.4%, YoY 9.1%
Adj. PAT came at Rs. 36.7 Cr vs QoQ Rs. 47.7 Cr, YoY Rs. 23.2 Cr
Quarter EPS is Rs. 105.2
Share is trading at P/E of 26.9x TTM EPS
*Marksans* has announced that one of the world's largest pharma funds Orbimed is picking up10.7% stake of Rs 365 cr. Also, funds to be used for growth as it is a zero debt co. *Positive*
*NHPC Ltd.* | *CMP* Rs. 27 | *M Cap* Rs. 27272 Cr | *52 W H/L* 28/20
(Nirmal Bang Retail Research)
*Result is below expectation*
Revenue from Operations came at Rs. 1341.5 Cr (-35.9% QoQ, -29.9% YoY) vs expectation of Rs. 2237.6 Cr, QoQ Rs. 2092.2 Cr, YoY Rs. 1913.6 Cr
EBIDTA came at Rs. 433.3 Cr (-63.2% QoQ, -22.5% YoY) vs expectation of Rs. 1113.3 Cr, QoQ Rs. 1178 Cr, YoY Rs. 559.4 Cr
EBITDA Margin came at 32.3% vs expectation of 49.8%, QoQ 56.3%, YoY 29.2%
Adj. PAT came at Rs. 290.1 Cr vs expectation of Rs. 361.4 Cr, QoQ Rs. 766.4 Cr, YoY Rs. 342.3 Cr
Quarter EPS is Rs. 0.3
Share is trading at P/E of 8.6x FY22E EPS
(Nirmal Bang Retail Research)
*Result is below expectation*
Revenue from Operations came at Rs. 1341.5 Cr (-35.9% QoQ, -29.9% YoY) vs expectation of Rs. 2237.6 Cr, QoQ Rs. 2092.2 Cr, YoY Rs. 1913.6 Cr
EBIDTA came at Rs. 433.3 Cr (-63.2% QoQ, -22.5% YoY) vs expectation of Rs. 1113.3 Cr, QoQ Rs. 1178 Cr, YoY Rs. 559.4 Cr
EBITDA Margin came at 32.3% vs expectation of 49.8%, QoQ 56.3%, YoY 29.2%
Adj. PAT came at Rs. 290.1 Cr vs expectation of Rs. 361.4 Cr, QoQ Rs. 766.4 Cr, YoY Rs. 342.3 Cr
Quarter EPS is Rs. 0.3
Share is trading at P/E of 8.6x FY22E EPS
*LG Balakrishnan & Brothers Ltd.* | *CMP* Rs. 353 | *M Cap* Rs. 1108 Cr | *52 W H/L* 362/200
(Nirmal Bang Retail Research)
*Result improved*
Revenue from Operations came at Rs. 499.1 Cr (0.2% QoQ, 40.1% YoY) vs QoQ Rs. 498.3 Cr, YoY Rs. 356.3 Cr
EBIDTA came at Rs. 88.7 Cr (-2.9% QoQ, 160.2% YoY) vs QoQ Rs. 91.3 Cr, YoY Rs. 34.1 Cr
EBITDA Margin came at 17.8% vs QoQ 18.3%, YoY 9.6%
Adj. PAT came at Rs. 49.5 Cr vs QoQ Rs. 53.6 Cr, YoY Rs. 6.8 Cr
Quarter EPS is Rs. 15.8
Share is trading at P/E of 9.2x TTM EPS
(Nirmal Bang Retail Research)
*Result improved*
Revenue from Operations came at Rs. 499.1 Cr (0.2% QoQ, 40.1% YoY) vs QoQ Rs. 498.3 Cr, YoY Rs. 356.3 Cr
EBIDTA came at Rs. 88.7 Cr (-2.9% QoQ, 160.2% YoY) vs QoQ Rs. 91.3 Cr, YoY Rs. 34.1 Cr
EBITDA Margin came at 17.8% vs QoQ 18.3%, YoY 9.6%
Adj. PAT came at Rs. 49.5 Cr vs QoQ Rs. 53.6 Cr, YoY Rs. 6.8 Cr
Quarter EPS is Rs. 15.8
Share is trading at P/E of 9.2x TTM EPS
*GE T&D India Ltd.* | *CMP* Rs. 139 | *M Cap* Rs. 3559 Cr | *52 W H/L* 149/58
(Nirmal Bang Retail Research)
*Result ok*
Revenue from Operations came at Rs. 904.5 Cr (-12.5% QoQ, 36.2% YoY) vs QoQ Rs. 1034.2 Cr, YoY Rs. 664.2 Cr
EBIDTA came at Rs. 44.6 Cr (-22.4% QoQ, -118.9% YoY) vs QoQ Rs. 57.5 Cr, YoY Rs. -235.7 Cr (last year some exceptional item before EBITDA)
EBITDA Margin came at 4.9% vs QoQ 5.6%, YoY -35.5%
Adj. PAT came at Rs. 40.6 Cr vs QoQ Rs. 30 Cr, YoY Rs. -187.1 Cr (lower tax resulted into higher PAT QoQ
Quarter EPS is Rs. 1.6
Share is trading at P/E of 31.6x FY22E EPS
(Nirmal Bang Retail Research)
*Result ok*
Revenue from Operations came at Rs. 904.5 Cr (-12.5% QoQ, 36.2% YoY) vs QoQ Rs. 1034.2 Cr, YoY Rs. 664.2 Cr
EBIDTA came at Rs. 44.6 Cr (-22.4% QoQ, -118.9% YoY) vs QoQ Rs. 57.5 Cr, YoY Rs. -235.7 Cr (last year some exceptional item before EBITDA)
EBITDA Margin came at 4.9% vs QoQ 5.6%, YoY -35.5%
Adj. PAT came at Rs. 40.6 Cr vs QoQ Rs. 30 Cr, YoY Rs. -187.1 Cr (lower tax resulted into higher PAT QoQ
Quarter EPS is Rs. 1.6
Share is trading at P/E of 31.6x FY22E EPS